About BIOLIFE4D BIOLIFE4D is a pioneering biotech company laser focused on leveraging advances in life sciences and tissue engineering to 3D bioprint a viable human heart suitable for transplant. The company aims to create a patient-specific heart hrough 3D bioprinting and the patients own cells.
3d Printing 3d Printing News Sliced Stratasys Oerlikon Blackbelt Nasa Cirque Du Soleil Https 3d Printing News 3d Printing Companies Coventry University
About Biolife4D Stock With BIOLIFE4D a patient-specific fully functioning heart will be created through 3D bioprinting and the patients own cells eliminating the challenges of organ rejection and long donor waiting lists that plague existing organ transplant methods.
Is biolife4d a good investment. BIOLIFE4D is less focused on new invention and more on optimizing a commercially viable process around the amazing things that have already been invented Morris told us. BIOLIFE4D is offering shares at 1000 USD per share with a minimum investment of 25 shares costing 25000 USD. BIOLIFE4D is committed to perfecting the technology to make viable organ replacement a safe accessible and affordable reality.
Investors are encouraged to read the Offering Circular and exhibits and consult with their tax legal or financial professional prior to investing. 06 2019 -- BIOLIFE4D a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant today announced it has launched its second. BIOLIFE4D is committed to perfecting the technology to make viable organ replacement a safe accessible and affordable reality.
Investing in BIOLIFE4D - BIOLIFE4D The Mission The Science The Team The Press Investment FAQs ContactInvestor Relations Invest Now At BIOLIFE4D we plan to bring revolutionary life-saving care to the masses and you now have an opportunity to be a part of this revolution by joining our team and becoming a sharehold. BioLife4D is planning an equity crowdfunding campaign in. It is amazing but BioLife4D needs our help.
Their goal is to do a 3D print of the HUMAN HEART that would be suitable for transplant. BIOLIFE4D is now offering shares at 1350 USD per share with a minimum investment of 80 shares for 1080 USD. BIOLIFE4D is offering shares at 1200 USD per share with a minimum investment of 90 shares for 1080 USD.
CHICAGO June 23 2018 -- BIOLIFE4D a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant today announced it. With respect to this investment we are still on the ground floor meaning an investment in BIOLIFE4D now would be done at our earliest valuation one we expect to change in the near future. BIOLIFE4D a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant today announced it has launched.
This would eliminate the wait for a transplant eliminate the organ rejection and increase lifespan. BIOLIFE4D has started a 50 million Reg A offering that will fund its work to create a replacement for the human heart through a 3-D printing process. BioLife4D is not a traditional model for a company and although there is huge potential for reward the technology requires investors to accept a lot.
With BIOLIFE4D a patient-specific fully functioning heart will be created through 3D bioprinting and the patients own cells eliminating the challenges of organ rejection and long donor waiting lists that. An investment in BIOLIFE4D is not a donation but rather an equity investment in the companys goal of bettering humanitys future. Doesnt this sound amazing though.
Today is a milestone day for BIOLIFE4D as we open our Regulation A offering to enable investment not only in our company but in the future of heart transplant treatment and technology. When you become a shareholder by purchasing stock you will be directly contributing towards our efforts to bring this life-saving technology to the market. Investors who are long the market and short these stocks would have returned more than 27 annually between 2015 and 2017.
We have already received tremendous interest and we are excited to welcome investors that are passionate about making a difference in the lives of so many said Steven Morris CEO BIOLIFE4D. BIOLIFE4D is committed to perfecting the technology to make viable organ replacement a safe accessible and affordable reality. It leverages advances in life sciences and cardiac tissue engineering to build human hearts suitable for implantation.
With BIOLIFE4D a patient-specific fully functioning heart will be created through 3D bioprinting and the patients own cells eliminating the challenges of organ rejection and long donor waiting lists that plague. BIOLIFE4D is a biotech company focused on viable organ replacement. Well BioLife4D wants to offer HOPE for heart disease patients.
Biolife4d Created 3d Prints Of A Tiny Human Heart With Patient Derived Cells Holistic Education Early Childhood Learning Learning And Development
Fundraising In Healthcare 3d Printing Part I So You Want To Pitch 3dheals Jason 3dprinting Additivemanufacturing Bioprint Health Care Prints Fundraising
Repost Regemat3d What Pore Size Do You Need Bioprinting 3dbioprinting Tissueengineering 3dprintedorgans Tissue Engineering Manufacturing Home Appliances
3d Printing 3d Systems Enters Bioprinting Agreement For Solid Organs Starting With The Lungs Https 3dprintingindu 3d Printing Industry Lunges 3d Printing
